Both hypothyroidism and hyperthyroidism increase atrial fibrillation inducibility in rats

Circulation: Arrhythmia and Electrophysiology

Volumn 6, Issue 5, 2013, Pages 952-959

  Zhang, Youhua ^a   Dedkov, Eduard I ^a   Teplitsky, Diana ^a   Weltman, Nathan Y ^b   Pol, Christine J ^a   Rajagopalan, Viswanathan ^a   Lee, Bianca ^a   Martin Gerdes, A ^a  

^a NEW YORK INSTITUTE OF TECHNOLOGY   (United States)

^b UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

Arrhythmias, cardiac; Atrial fibrillation; Electrophysiology; Thyroid hormones

Indexed keywords

CONNEXIN 43; LIOTHYRONINE; PLACEBO; THYROTROPIN; THYROXINE; THYROID HORMONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIASTOLE; DISEASE ASSOCIATION; FEMALE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HEART FUNCTION; HEART HEMODYNAMICS; HEART MUSCLE FIBROSIS; HEART MUSCLE REFRACTORY PERIOD; HEART RATE; HEART VENTRICLE HYPERTROPHY; HYPERTHYROIDISM; HYPOTHYROIDISM; IMMUNOHISTOCHEMISTRY; LIOTHYRONINE BLOOD LEVEL; NONHUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RAT; SYSTOLE; THYROIDECTOMY; THYROTROPIN BLOOD LEVEL; TREATMENT DURATION; ANIMAL; BLOOD; DISEASE MODEL; ECHOCARDIOGRAPHY; ECHOGRAPHY; ELECTROPHYSIOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART FUNCTION TEST; HEMODYNAMICS; PATHOPHYSIOLOGY; RANDOMIZATION; SPRAGUE DAWLEY RAT; ATRIAL FIBRILLATION; COMPLICATION;

ARRHYTHMIAS, CARDIAC; ATRIAL FIBRILLATION; ELECTROPHYSIOLOGY; THYROID HORMONES;

ANIMALS; ATRIAL FIBRILLATION; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODYNAMICS; HYPERTHYROIDISM; HYPOTHYROIDISM; IMMUNOHISTOCHEMISTRY; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; THYROID HORMONES; THYROIDECTOMY;

EID: 84891536090     PISSN: 19413149     EISSN: 19413084     Source Type: Journal    
DOI: 10.1161/CIRCEP.113.000502     Document Type: Article

References (32)

1. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Kay GN, Le Huezey JY, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann LS, Smith SC Jr, Priori SG, Estes NA, 3rd, Ezekowitz MD, Jackman WM, January CT, Page RL, Slotwiner DJ, Stevenson WG, Tracy CM, Jacobs AK, Anderson JL, Albert N, Buller CE, Creager MA, Ettinger SM, Guyton RA, Hochman JS, Kushner FG, Ohman EM, Tarkington LG, Yancy CW. 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines. Circulation. 2011;123:e269-367.
2. Maisel WH, Stevenson LW. Atrial fibrillation in heart failure: epidemiology, pathophysiology, and rationale for therapy. Am J Cardiol. 2003;91(6 A):2D-8D.
3. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, Ford E, Furie K, Go A, Greenlund K, Haase N, Hailpern S, Ho M, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott M, Meigs J, Mozaffarian D, Nichol G, O'Donnell C, Roger V, Rosamond W, Sacco R, Sorlie P, Stafford R, Steinberger J, Thom T, Wasserthiel-Smoller S, Wong N, Wylie-Rosett J, Hong Y. Heart disease and stroke statistics-2009 update: a report from the American Heart Association statistics committee and stroke statistics subcommittee. Circulation. 2009;119:480-486.
4. Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med. 2001;344:501-509.
5. Tang YD, Kuzman JA, Said S, Anderson BE, Wang X, Gerdes AM. Low thyroid function leads to cardiac atrophy with chamber dilatation, impaired myocardial blood flow, loss of arterioles, and severe systolic dysfunction. Circulation. 2005;112:3122-3130.
6. Gerdes AM, Iervasi G. Thyroid replacement therapy and heart failure. Circulation. 2010;122:385-393.
7. Biondi B. Mechanisms in endocrinology: heart failure and thyroid dysfunction. Eur J Endocrinol. 2012;167:609-618.
8. Siddiqui AS, D'Costa DF, Moore-Smith B. Covert hypothyroidism with weight loss and atrial fibrillation. Br J Clin Pract. 1993;47:268.
9. Wong PS, Hee FL, Lip GY. Atrial fibrillation and the thyroid. Heart. 1997;78:623-624.
10. Tajiri J, Morita M, Higashi K, Sato T. Masked thyroid dysfunction in elderly patients with atrial fibrillation. Arch Intern Med. 1985;145:1140.
11. Selmer C, Olesen JB, Hansen ML, Lindhardsen J, Olsen AM, Madsen JC, Faber J, Hansen PR, Pedersen OD, Torp-Pedersen C, Gislason GH. The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study. BMJ. 2012;345:e7895.
12. Arnsdorf MF, Childers RW. Atrial electrophysiology in experimental hyperthyroidism in rabbits. Circ Res. 1970;26:575-581.
13. Hu Y, Jones SV, Dillmann WH. Effects of hyperthyroidism on delayed rectifier K+ currents in left and right murine atria. Am J Physiol. 2005;289:H1448-1455.
14. Chen WJ, Yeh YH, Lin KH, Chang GJ, Kuo CT. Molecular characterization of thyroid hormone-inhibited atrial L-type calcium channel expression: implication for atrial fibrillation in hyperthyroidism. Basic Res Cardiol. 2011;106:163-174.
15. Liu Y, Redetzke RA, Said S, Pottala JV, De Escobar GM, Gerdes AM. Serum thyroid hormone levels may not accurately reflect thyroid tissue levels and cardiac function in mild hypothyroidism. Am J Physiol. 2008;294:H2137-2143.
16. Chen YF, Weltman NY, Li X, Youmans S, Krause D, Gerdes AM. Improvement of left ventricular remodeling after myocardial infarction with eight weeks L-thyroxine treatment in rats. J Transl Med. 2013;11:40.
17. Smeets JL, Allessie MA, Lammers WJ, Bonke FI, Hollen J. The wavelength of the cardiac impulse and reentrant arrhythmias in isolated rabbit atrium. The role of heart rate, autonomic transmitters, temperature, and potassium. Circ Res. 1986;58:96-108.
18. Chen YC, Chen SA, Chen YJ, Chang MS, Chan P, Lin CI. Effects of thyroid hormone on the arrhythmogenic activity of pulmonary vein cardiomyocytes. J Am Coll Cardiol. 2002;39:366-372.
19. Wustmann K, Kucera JP, Zanchi A, Burow A, Stuber T, Chappuis B, Diem P, Delacrétaz E. Activation of electrical triggers of atrial fibrillation in hyperthyroidism. J Clin Endocrinol Metab. 2008;93:2104-2108.
20. Watanabe H, Ma M, Washizuka T, Komura S, Yoshida T, Hosaka Y, Hatada K, Chinushi M, Yamamoto T, Watanabe K, Aizawa Y. Thyroid hormone regulates mRNA expression and currents of ion channels in rat atrium. Biochem Biophys Res Commun. 2003;308:439-444.
21. Yu Z, Wang T, Xu L, Huang CX. Thyroid hormone increased L-type calcium channel mRNA expression and L-type calcium current of myocytes in rabbits. Biomed Mater Eng. 2012;22:49-55.
22. Kreuzberg U, Theissen P, Schicha H, Schroder F, Mehlhorn U, De Vivie ER, Boknik P, Neumann J, Grohe C, Herzig S. Single-channel activity and expression of atrial L-type Ca (2+) channels in patients with latent hyperthyroidism. Am J Physiol. 2000;278:H723-730.
23. Stock A, Sies H, Stahl W. Enhancement of gap junctional communication and connexin43 expression by thyroid hormones. Biochem Pharmacol. 1998;55:475-479.
24. Mitasíková M, Lin H, Soukup T, Imanaga I, Tribulová N. Diabetes and thyroid hormones affect connexin-43 and PKC-epsilon expression in rat heart atria. Physiol Res. 2009;58:211-217.
25. Burstein B, Nattel S. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J Am Coll Cardiol. 2008;51:802-809.
26. Weltman NY, Wang D, Redetzke RA, Gerdes AM. Longstanding hyperthyroidism is associated with normal or enhanced intrinsic cardiomyocyte function despite decline in global cardiac function. PLoS One. 2012;7:e46655.
27. Gerritsen RJ, Van Den Brom WE, Stokhof AA. Relationship between atrial fibrillation and primary hypothyroidism in the dog. Vet Q. 1996;18:49-51.
28. Chen WJ, Lin KH, Lee YS. Molecular characterization of myocardial fibrosis during hypothyroidism: evidence for negative regulation of the proalpha1 (I) collagen gene expression by thyroid hormone receptor. Mol Cell Endocrinol. 2000;162:45-55.
29. Light P, Shimoni Y, Harbison S, Giles W, French RJ. Hypothyroidism decreases the ATP sensitivity of KATP channels from rat heart. J Membr Biol. 1998;162:217-223.
30. Seppet EK, Kolar F, Dixon IM, Hata T, Dhalla NS. Regulation of cardiac sarcolemmal Ca2+ channels and Ca2+ transporters by thyroid hormone. Mol Cell Biochem. 1993;129:145-159.
31. Ferrer T, Arín RM, Casis E, Torres-Jacome J, Sanchez-Chapula JA, Casis O. Mechanisms responsible for the altered cardiac repolarization dispersion in experimental hypothyroidism. Acta Physiol (Oxf). 2012;204:502-512.
32. Iervasi G, Pingitore A, Landi P, Raciti M, Ripoli A, Scarlattini M, L'Abbate A, Donato L. Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease. Circulation. 2003;107:708-713.